The HVTN maintains a vigorous program to facilitate the development of
novel vaccine approaches.
The novel vaccine approach also may have applications beyond rabies, particularly in developing a vaccine against white - nose syndrome, a disease that is decimating bat colonies around the country.
Not exact matches
«Engineering
novel methods of delivering monoclonal antibodies could be an important
approach in the fight against infection and in unique treatment situations,» said senior author David B. Weiner, PhD, a professor of Pathology and Laboratory Medicine and chair of the Gene Therapy and
Vaccine Program.
Although researchers and colleagues are extremely hopeful that this
novel approach will generate an effective
vaccine against TB and potentially other infectious diseases, Dr. Divangahi added a word of caution.
The
vaccine is a «very
novel approach for the treatment of obesity,» says Matthias Tschöp, an obesity researcher at the University of Cincinnati in Ohio.
The Transcriptomics Core Facility supports a systems biology
approach in
vaccine development focusing on the identification of transcriptomic correlates of
vaccine immunogenicity and efficacy for a range of
novel and licensed
vaccines using PBMC or whole - blood and BAL fluid samples.
The second focus on my research is the development of
novel therapeutic
vaccine approaches for cancer.
discovery of new
vaccine targets by innovative
approaches that allow the identification of non-classical
vaccine antigens like non-protein antigens and subdominant epitopes and
novel protein candidates
He has made several important contributions in this area including identifying a new strain of CHIKV virus, identification of host cellular targets of HIV accessory genes, new
novel DNA
vaccine approaches for HIV, CHIKV, RSV, Dengue, MERS and Zika among others.
There her research focused on inventing molecular, bead and array - based
approaches to enable
novel vaccine discovery against infectious and chronic diseases At the University of Texas Southwestern Medical she pursued technologies that became the basis of a Texas biotechnology company that was ultimately acquired by MacroGenics, Inc..